Wilcoxia P Tablet is a combination analgesic and anti-inflammatory medication containing Etoricoxib 60 mg and Paracetamol 325 mg. Etoricoxib, a selective cyclooxygenase-2 (COX-2) inhibitor, provides effective relief from pain and inflammation by selectively inhibiting the COX-2 enzyme responsible for prostaglandin synthesis, thereby minimizing gastrointestinal side effects commonly associated with non-selective NSAIDs. Paracetamol acts as an analgesic and antipyretic, enhancing pain relief through central inhibition of prostaglandin synthesis. This combination is indicated for the management of acute and chronic musculoskeletal pain, osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, and postoperative pain. Wilcoxia P Tablet offers rapid onset of action with sustained analgesic and anti-inflammatory effects, improving patient comfort and mobility. It is generally well tolerated; however, caution is advised in patients with a history of cardiovascular disease, hepatic or renal impairment, and gastrointestinal disorders. The medication should be used at the lowest effective dose for the shortest duration necessary to reduce potential risks. Contraindications include hypersensitivity to either component, active peptic ulcer disease, and severe hepatic or renal dysfunction. Wilcoxia P Tablet should be administered under medical supervision with regular monitoring for adverse effects.